MGC Diagnostics (MGCD) Reports Q2 EPS of $0.10

MGC Diagnostics (NASDAQ: MGCD) reported Q2 EPS of $0.10, versus $0.02 reported last year. Revenue for the quarter came in at $9.4 million, versus $8.7 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Southland Holdings (SLND) Misses Q2 EPS by 122c